Related Experiment Video
Updated: Aug 24, 2025

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.7K
The Roles of microRNA miR-185 in Digestive Tract Cancers
Esmaeel Babaeenezhad1,2,3, Fakhraddin Naghibalhossaini4, Masoumeh Rajabibazl5
1Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran.
Non-Coding RNA
|October 26, 2022
Summary
MicroRNA miR-185 plays a dual role in digestive tract cancers, acting as both a tumor suppressor and an oncogene. Its expression levels offer potential for diagnosing and treating these serious malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Digestive tract cancers pose a significant global health challenge.
- MicroRNA miR-185 has emerged as a key player in the development of these malignant tumors.
- Expression levels of miR-185 are linked to various clinical indicators, including tumor progression and patient outcomes.
Purpose of the Study:
- To review and synthesize current research on the role of miR-185 in digestive tract cancers.
- To evaluate the diagnostic and prognostic potential of miR-185.
- To explore miR-185's implications for future therapeutic strategies.
Main Methods:
- Literature review and critical evaluation of existing studies.
- Analysis of miR-185's involvement in both tumor-suppressive and oncogenic pathways.
- Investigation of upstream regulatory mechanisms and downstream effects of miR-185.
Main Results:
- miR-185 exhibits a complex, dual function in digestive tract cancers.
- Expression patterns of miR-185 correlate with tumor size, metastasis, and patient survival.
- miR-185 demonstrates potential as a biomarker for diagnosis and prognosis.
Conclusions:
- miR-185 is critically involved in the pathogenesis of digestive tract cancers.
- Further research into miR-185 could lead to novel diagnostic tools and targeted therapies.
- Understanding miR-185's regulatory network is crucial for advancing cancer treatment.
Related Concept Videos
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
lncRNA - Long Non-coding RNAs
8.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K

